Trials / Recruiting
RecruitingNCT06633250
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 8 Months
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to demonstrate that the growth of infants fed with the Test Formula is non-inferior those fed with the Control Formula. The study will also evaluate the gastrointestinal tolerance, quatliy of life and acceptability of the new rice protein-based formula in infants with cow's milk protein allergy (CMPA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Test Formula | Hydrolyzed rice protein formula |
| OTHER | Control Formula | Commercially available extensively hydrolyzed cow's milk formula |
Timeline
- Start date
- 2024-10-25
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2024-10-09
- Last updated
- 2025-12-26
Locations
19 sites across 3 countries: Germany, Italy, Poland
Source: ClinicalTrials.gov record NCT06633250. Inclusion in this directory is not an endorsement.